Department of Molecular Biology and Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého tř. 1946/1, 612 42 Brno, Czech Republic.
Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého tř. 1946/1, 612 42 Brno, Czech Republic.
Viruses. 2020 Jan 29;12(2):154. doi: 10.3390/v12020154.
Recently, the problem of viral infection, particularly the infection with herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), has dramatically increased and caused a significant challenge to public health due to the rising problem of drug resistance. The antiherpetic drug resistance crisis has been attributed to the overuse of these medications, as well as the lack of new drug development by the pharmaceutical industry due to reduced economic inducements and challenging regulatory requirements. Therefore, the development of novel antiviral drugs against HSV infections would be a step forward in improving global combat against these infections. The incorporation of biologically active natural products into anti-HSV drug development at the clinical level has gained limited attention to date. Thus, the search for new drugs from natural products that could enter clinical practice with lessened resistance, less undesirable effects, and various mechanisms of action is greatly needed to break the barriers to novel antiherpetic drug development, which, in turn, will pave the road towards the efficient and safe treatment of HSV infections. In this review, we aim to provide an up-to-date overview of the recent advances in natural antiherpetic agents. Additionally, this paper covers a large scale of phenolic compounds, alkaloids, terpenoids, polysaccharides, peptides, and other miscellaneous compounds derived from various sources of natural origin (plants, marine organisms, microbial sources, lichen species, insects, and mushrooms) with promising activities against HSV infections; these are in vitro and in vivo studies. This work also highlights bioactive natural products that could be used as templates for the further development of anti-HSV drugs at both animal and clinical levels, along with the potential mechanisms by which these compounds induce anti-HSV properties. Future insights into the development of these molecules as safe and effective natural anti-HSV drugs are also debated.
最近,病毒感染问题,特别是单纯疱疹病毒 1 型(HSV-1)和 2 型(HSV-2)的感染,由于耐药问题的日益严重,对公共卫生造成了重大挑战。抗疱疹药物的耐药危机归因于这些药物的过度使用,以及制药行业由于经济诱因减少和挑战性监管要求而缺乏新药开发。因此,开发针对 HSV 感染的新型抗病毒药物将是改善全球对抗这些感染的重要一步。将具有生物活性的天然产物纳入抗 HSV 药物开发的临床水平在很大程度上引起了人们的关注。因此,迫切需要从天然产物中寻找新的药物,这些药物进入临床实践时耐药性降低、不良影响较小,并且具有多种作用机制,以打破新型抗疱疹药物开发的障碍,从而为 HSV 感染的有效和安全治疗铺平道路。在这篇综述中,我们旨在提供关于天然抗疱疹药物的最新进展的最新概述。此外,本文涵盖了大量酚类化合物、生物碱、萜类化合物、多糖、肽和其他源自天然来源(植物、海洋生物、微生物来源、地衣物种、昆虫和蘑菇)的各种化合物,这些化合物具有对抗 HSV 感染的有希望的活性;这些是体外和体内研究。本文还重点介绍了可作为进一步开发动物和临床水平抗 HSV 药物的模板的生物活性天然产物,以及这些化合物诱导抗 HSV 特性的潜在机制。还讨论了未来对这些分子作为安全有效的天然抗 HSV 药物的发展的深入了解。